ID: ALA324632

Max Phase: Preclinical

Molecular Formula: C6H13NO3

Molecular Weight: 147.17

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): 1,6-Dideoxynojirimycin
Synonyms from Alternative Forms(1):

    Canonical SMILES:  C[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O

    Standard InChI:  InChI=1S/C6H13NO3/c1-3-5(9)6(10)4(8)2-7-3/h3-10H,2H2,1H3/t3-,4+,5-,6-/m1/s1

    Standard InChI Key:  VYOCYWDJTQRZLC-JGWLITMVSA-N

    Associated Targets(Human)

    Beta-glucocerebrosidase 14647 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Neutral alpha-glucosidase AB 90 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Alpha-L-fucosidase I 304 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Beta-mannosidase 62 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Splenocyte 1641 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: YesOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 147.17Molecular Weight (Monoisotopic): 147.0895AlogP: -1.94#Rotatable Bonds: 0
    Polar Surface Area: 72.72Molecular Species: BASEHBA: 4HBD: 4
    #RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 12.93CX Basic pKa: 8.62CX LogP: -1.84CX LogD: -3.08
    Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.32Np Likeness Score: 1.98

    References

    1. Berger A, Dax K, Gradnig G, Grassberger V, Stutz A, Ungerank M, Legler G, Bause E.  (1992)  Synthesis and biological activity of C-6 modified derivatives of the glucosidase inhibitor 1-deoxynojirimycin.,  (1): [10.1016/S0960-894X(00)80648-4]
    2. Dumas DP, Kajimoto T, Liu KK, Wong C, Berkowitz DB, Danieshefsky SJ.  (1992)  Azasugar and glycal inhibitors of -L-fucosidase,  (1): [10.1016/S0960-894X(00)80649-6]
    3. Zhou J, Zhang Y, Zhou X, Zhou J, Zhang LH, Ye XS, Zhang XL..  (2008)  An expeditious one-pot synthesis of 1,6-dideoxy-N-alkylated nojirimycin derivatives and their inhibitory effects on the secretion of IFN-gamma and IL-4.,  16  (4): [PMID:18060793] [10.1016/j.bmc.2007.11.036]

    Source